Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile
By Sriparna Roy (Reuters) – Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by recording nearly $550 million in “pre-launch inventory” in its financial statements, a filing showed on Wednesday. The move is unusual as it comes more than a year before the drug,…
